Comparison of the Effect of Fluoride Remineralizer Gel and Foam
NCT ID: NCT02490592
Last Updated: 2015-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
58 participants
INTERVENTIONAL
2014-03-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
to verified the activity (visual scores) and the dimensional changes of whit spot lesions (with WHO probe and millimeter ruler), risk for caries (CAMBRA) and OHI-S (Simplified Oral Hygiene Index) of children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dental Fluorosis Risk by the Use of Acidulated Fluoride Dentifrice
NCT03761485
Effect of Different Remineralizing Agents on White Spot Lesions Treatment in Children
NCT06821724
Remineralization Potential of PRG Barrier Coat Versus Fluoride Varnish in White Spot Lesions in Permanent Anterior Teeth of Children
NCT06986551
Effect of pH and Fluoride Concentration of Dentifrices on Caries Control
NCT01049503
In Vivo Evaluation of an Experimental Fluoride-containing Dentifrice With Hydrocolloid
NCT02809014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
G1
Thirty children aged seven to twelve years who had seventy one active white spots lesions in permanent anterior teeth randomly assigned to four or eight weekly intervals applications of fluoride foam, Flúor Care (NaF 1.23%), to verified the activity (visual scores) and the dimensional changes of whit spot lesions (with WHO probe and millimeter ruler), caries Management by Risk Assessment (CAMBRA) and OHI-S (Simplified Oral Hygiene Index) of children.
Fluoride Foam
Fluoride foam - Flúor Care (NaF 1.23%) (G1)
G2
Twenty-eight children aged seven to twelve years who had seventy five active white spots lesions in permanent anterior teeth randomly assigned to four or eight weekly intervals applications of fluoride gel, Flugel FFA (NaF 1.23%), to verified the activity (visual scores) and the dimensional changes of whit spot lesions (with WHO probe and millimeter ruler), caries Management by Risk Assessment (CAMBRA) and OHI-S (Simplified Oral Hygiene Index) of children.
Fluoride gel
Fluoride gel - Flugel FFA (NaF 1.23%) (G2)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluoride Foam
Fluoride foam - Flúor Care (NaF 1.23%) (G1)
Fluoride gel
Fluoride gel - Flugel FFA (NaF 1.23%) (G2)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
7 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Cruzeiro do Sul
OTHER
University Center of João Pessoa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
JAINARA MARIA SOARES FERREIRA
JAINARA MARIA SOARES FERREIRA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jainara Ferreira, Phd
Role: PRINCIPAL_INVESTIGATOR
UNIPÊ
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAAE: 25687413.8.000.5176
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.